Sabby Management, LLC Sangamo Therapeutics, Inc Transaction History

Sabby Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $147,804 - $215,760	-11,326 Reduced 6.73%	156,913 $2.66 Million
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $362,831 - $516,839	26,103 Added 18.36%	168,239 $2.39 Million
Q1 2018 May 15, 2018	BUY	$16.7 - $26.35 $2.37 Million - $3.75 Million	142,136 New	142,136 $2.7 Million

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $294M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.